Skip to main content
Premium Trial:

Request an Annual Quote

Jubilant Licenses Pathways Database to Novartis

NEW YORK, Dec. 4 (GenomeWeb News) - Bioinformatics and chemoinformatics service provider Jubilant Biosys has licensed its PathArt database of manually curated pathways to Novartis, the company said today.


PathArt comprises more than 450 signaling, metabolic, and disease-specific pathways, Jubilant said. It also includes coverage on disease-specific pathways in certain cancers, arthritis, Alzheimer's disease, asthma, multiple sclerosis, Parkinson's disease, diabetes, and atherosclerosis. 


The database is set up to enable researchers to map data generated from experiments directly into the pathways.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.